Endomag has announced that the University of California, San Francisco (UCSF) has become the first US site to adopt Magseed™ as its standard of care for localization of impalpable breast lesions.

CAMBRIDGE, England & SAN FRANCISCO--(BUSINESS WIRE)--Endomag, the cancer healthcare company, announced today that the University of California, San Francisco (UCSF) has become the first US site to ...

Breast cancer patients in the Midland now have access to a new option when preparing for breast cancer surgery. Magseed, offered at MidMichigan Medical Center – Midland, is a simpler, more effective ...

[ooyala player_id=”c660b791c3704ff69d4162d7adb7c4a1″ auto=”true” width=”1920″ height=”1080″ pcode=”d2b3E6s5rDofer9uw9hhgMxCRs6U” code ...

A new and more accurate option in breast cancer surgery called Magseed is giving women better outcomes, with fewer needing repeat surgeries because their cancer wasn't completely removed. Before a ...

For nearly 50 years, patients with breast cancer requiring a lumpectomy have undergone a multi-step process on the day of surgery. To locate the site of a tumor, the first step has been a procedure ...

Magseed technology guides surgeons during a breast lumpectomy to simplify treatment and improve patient experience Endomag, the cancer healthcare company, announced today that the University of ...